Risks of Overdosing Effexor
Recently, the FDA reviewed the existing suicide risk among youngsters who are taking different antidepressants. And in December 13, 2012 it announced a conference among a number of experts that should re-consider some new medical information on this increased risk of suicidal thoughts and behavior that is common for youngsters that take antidepressants on a regular basis. This meeting is the second one, as the first one took place in February and September. It involved such serious questions as suicidality among pediatric patients. The FDA states that it definitely wants to modify available antidepressants based on all these findings.
October 25, 2012: the manufacturer of a drug known as Effexor warns doctors of the existing overdose risk. Wyeth, a manufacturer of such a drug, sent a letter to a wide range of healthcare providers to inform them of diverse chances to the prescribing info that this drug should contain. It is advised for doctors to limit a number of tablets that they usually prescribe to their patients who used to take Effexor. That’s because of the existing risk of overdosing it. If to believe Wyeth: “All the prescriptions for Effexor should be written for a small quality of pills consistent with the right patient management. It is necessary to decrease a risk of overdosing this medication.”
July 6, 2012: the so-called MAN, which is a private non-profit organization devoted to different ethical problems in the modern medicine, tried to criticize the Effexor maker for not warning adequately patients about the risk of homicidal behavior connected with the usage of this medication. This data was included in the prescription label of this drug only after several events of homicidal thoughts among patients who were taking Effexor. The Medical Accountability Network: “These warnings were not announced properly. So, Wyeth failed to send necessary letters to doctors and issue warning labels that announce about this risk.”
July, 2012: the FDA claims that the usage of Effexor and diverse migraine medications can be very risky for many patients. This organization warns people about the risks connected with the usage of this medication, especially combined with triptans, which are utilized to treat migraines, and serotonin reuptake inhibitors. This combination may lead to some life-threatening conditions, like a serotonin syndrome. Finally, the FDA also issued a special public health advisory. And it says that there is a high risk of suicidal behavior in patients that have being treated with some antidepressants, including Effexor.
